hrcak mascot   Srce   HID

Acta Pharmaceutica, Vol.62 No.1 Ožujak 2012.

Izvorni znanstveni članak
https://doi.org/10.2478/v10007-012-0001-6

Eudraginated polymer blends: A potential oral controlled drug delivery system for theophylline

MARTINS EMEJE ; Department of Pharmaceutical Technology and Raw Materials Development, National Institute for Pharmaceutical Research and Development (NIPRD), Abuja, Nigeria
LUCY JOHN-AFRICA ; Department of Pharmacology and Toxicology, National Institute for Pharmaceutical Research and Development (NIPRD), Abuja, Nigeria
YETUNDE ISIMI ; Department of Pharmaceutical Technology and Raw Materials Development, National Institute for Pharmaceutical Research and Development (NIPRD), Abuja, Nigeria
OLOBAYO KUNLE ; Department of Pharmaceutical Technology and Raw Materials Development, National Institute for Pharmaceutical Research and Development (NIPRD), Abuja, Nigeria
SABINUS OFOEFULE ; Department of Pharmaceutical Technology and Industrial Pharmacy, University of Nigeria, Nsukka, Enugu state, Nigeria

Puni tekst: engleski, pdf (136 KB) str. 71-82 preuzimanja: 409* citiraj
APA 6th Edition
EMEJE, M., JOHN-AFRICA, L., ISIMI, Y., KUNLE, O. i OFOEFULE, S. (2012). Eudraginated polymer blends: A potential oral controlled drug delivery system for theophylline. Acta Pharmaceutica, 62 (1), 71-82. https://doi.org/10.2478/v10007-012-0001-6
MLA 8th Edition
EMEJE, MARTINS, et al. "Eudraginated polymer blends: A potential oral controlled drug delivery system for theophylline." Acta Pharmaceutica, vol. 62, br. 1, 2012, str. 71-82. https://doi.org/10.2478/v10007-012-0001-6. Citirano 26.09.2018.
Chicago 17th Edition
EMEJE, MARTINS, LUCY JOHN-AFRICA, YETUNDE ISIMI, OLOBAYO KUNLE i SABINUS OFOEFULE. "Eudraginated polymer blends: A potential oral controlled drug delivery system for theophylline." Acta Pharmaceutica 62, br. 1 (2012): 71-82. https://doi.org/10.2478/v10007-012-0001-6
Harvard
EMEJE, M., et al. (2012). 'Eudraginated polymer blends: A potential oral controlled drug delivery system for theophylline', Acta Pharmaceutica, 62(1), str. 71-82. doi: https://doi.org/10.2478/v10007-012-0001-6
Vancouver
EMEJE M, JOHN-AFRICA L, ISIMI Y, KUNLE O, OFOEFULE S. Eudraginated polymer blends: A potential oral controlled drug delivery system for theophylline. Acta Pharm. [Internet]. 31.03.2012. [pristupljeno 26.09.2018.];62(1):71-82. doi: https://doi.org/10.2478/v10007-012-0001-6
IEEE
M. EMEJE, L. JOHN-AFRICA, Y. ISIMI, O. KUNLE i S. OFOEFULE, "Eudraginated polymer blends: A potential oral controlled drug delivery system for theophylline", Acta Pharmaceutica, vol.62, br. 1, str. 71-82, ožujak 2012. [Online]. doi: https://doi.org/10.2478/v10007-012-0001-6

Sažetak
Sustained release (SR) dosage forms enable prolonged and continuous deposition of the drug in the gastrointestinal (GI) tract and improve the bioavailability of medications characterized by a narrow absorption window. In this study, a new strategy is proposed for the development of SR dosage forms for theophylline (TPH). Design of the delivery system was based on a sustained release formulation, with a modified coating technique and swelling features aimed to extend the release time of the drug. Different polymers, such as Carbopol 71G (CP), sodium carboxymethylcellulose (SCMC), ethylcellulose (EC) and their combinations were tried. Prepared matrix tablets were coated with a 5 % (m/m) dispersion of Eudragit (EUD) in order to get the desired sustained release profile over a period of 24 h. Various formulations were evaluated for drug concentration and in vitro drug release. It was found that the in vitro drug release rate decreased with increasing the amount of polymer. Coating with EUD resulted in a significant lag phase in the first two hours of dissolution in the acidic pH of simulated gastric fluid (SGF) due to decreased water uptake, and hence decreased driving force for drug release. Release became faster in the alkaline pH of simulated intestinal fluid (SIF) owing to increased solubility of both the coating and matrixing agents. The optimized formulation was subjected to in vivo studies in rabbits and the pharmacokinetic parameters of developed formulations were compared with the commercial (Asmanyl®) formulation. Asmanyl® tablets showed faster absorption (tmax 4.0 h) compared to the TPH formulation, showing a tmax value of 8.0 h. The cmax and AUC values of TPH formulation were significantly (p < 0.05) higher than those for Asmanyl®, revealing relative bioavailability of about 136.93 %. Our study demonstrated the potential usefulness of eudraginated polymers for the oral delivery of the sparingly soluble drug theophylline.

Ključne riječi
theophylline; polymer blends; modified release; in vitro release; in vivo release

Hrčak ID: 74828

URI
https://hrcak.srce.hr/74828

[hrvatski]

Posjeta: 605 *